Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
Eshan U. Patel, Evan M. Bloch, William Clarke, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 2
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky, William A. Werbel, Robin K. Avery, et al.
JAMA (2021) Vol. 325, Iss. 21, pp. 2204-2204
Open Access | Times Cited: 951
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Brian J. Boyarsky, William A. Werbel, Robin K. Avery, et al.
JAMA (2021) Vol. 325, Iss. 17, pp. 1784-1784
Open Access | Times Cited: 523
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 397, Iss. 10289, pp. 2049-2059
Open Access | Times Cited: 471
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
Hassen Kared, Andrew D. Redd, Evan M. Bloch, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 5
Open Access | Times Cited: 252
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Yannick Galipeau, Matthew Greig, George Liu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 242
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic
Joane Matta, Emmanuel Wiernik, Olivier Robineau, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 1, pp. 19-19
Open Access | Times Cited: 230
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Thomas Perkmann, Nicole Perkmann‐Nagele, Thomas Köller, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 176
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 176
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
Victoria Hall, Victor H. Ferreira, Matthew Ierullo, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3980-3989
Open Access | Times Cited: 143
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
Jan Van Elslande, Matthijs Oyaert, Scott Ailliet, et al.
Journal of Clinical Virology (2021) Vol. 136, pp. 104765-104765
Open Access | Times Cited: 136
The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
Bezawit A. Woldemeskel, Andrew H. Karaba, Caroline C. Garliss, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 7, pp. 1268-1270
Open Access | Times Cited: 136
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
Darius F. Ruether, Golda Schaub, Paul Duengelhoef, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 1, pp. 162-172.e9
Open Access | Times Cited: 133
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Florent Malard, Béatrice Gaugler, Joël Gozlan, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 125
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
Binod Dhakal, Sameem Abedin, Timothy S. Fenske, et al.
Blood (2021) Vol. 138, Iss. 14, pp. 1278-1281
Open Access | Times Cited: 124
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Andrew H. Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 4, pp. 1253-1260
Open Access | Times Cited: 98
A comparative review of immunoassays for COVID-19 detection
Elham Mohit, Zahra Rostami, Hossein Vahidi
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 6, pp. 573-599
Open Access | Times Cited: 96
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
Julien Favresse, Constant Gillot, Laura Di Chiaro, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 90
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
Antonin Bal, Bruno Pozzetto, Mary‐Anne Trabaud, et al.
Clinical Chemistry (2021) Vol. 67, Iss. 5, pp. 742-752
Open Access | Times Cited: 82
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
William R. Morgenlander, Stephanie Henson, Daniel R. Monaco, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 7
Open Access | Times Cited: 81
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
Maria Krutikov, Tom Palmer, Gokhan Tut, et al.
The Lancet Healthy Longevity (2021) Vol. 3, Iss. 1, pp. e13-e21
Open Access | Times Cited: 80
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 5, pp. 1458-1472
Open Access | Times Cited: 79
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Arturo Casadevall, Liise‐anne Pirofski, Michael J. Joyner
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 77
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 72
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia
Francesco Menichetti, Patrizia Popoli, Maria Puopolo, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2136246-e2136246
Open Access | Times Cited: 62
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Lise J Estcourt, Leon Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top